Park Ha Biological Technology Co., Ltd.
PHH · NASDAQ
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $547 | $1,034 | $575 | $73 |
| + Debt | $70 | $31 | $26 | $35 |
| Enterprise Value | -$477 | -$1,002 | -$548 | -$37 |
| Revenue | $2,382 | $2,459 | $1,919 | $931 |
| % Growth | -3.1% | 28.1% | 106.2% | – |
| Gross Profit | $2,187 | $2,148 | $1,410 | $620 |
| % Margin | 91.8% | 87.4% | 73.5% | 66.6% |
| EBITDA | $816 | $1,201 | $221 | -$445 |
| % Margin | 34.3% | 48.8% | 11.5% | -47.8% |
| Net Income | $479 | $852 | $191 | -$485 |
| % Margin | 20.1% | 34.6% | 10% | -52.1% |
| EPS Diluted | 0.018 | 0.033 | 0.007 | -0.019 |
| % Growth | -43.7% | 345.2% | 139.5% | – |
| Operating Cash Flow | $960 | $127 | $1,442 | -$498 |
| Capital Expenditures | -$86 | -$23 | -$12 | -$13 |
| Free Cash Flow | $875 | $104 | $1,430 | -$511 |